Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6250199 | 0.94 | CRHBP (0.37) | CRHBPCRHR2 | |
| SCHEMBL5917100 | 0.85 | CRHBP (0.50) | CRHBPCRHR2 | |
| SCHEMBL6230086 | 0.82 | LMNA (0.34) | CRHBPCRHR2 | |
| SCHEMBL6232248 | 0.77 | GRIN1 (0.39) | CRHBPCRHR2 | |
| SCHEMBL5608359 | 0.72 | CRHBP (0.46) | CRHBPCRHR2 | |
| SCHEMBL5803834 | 0.72 | PKM (0.45) | CRHBPCRHR2 | |
| SCHEMBL7173119 | 0.70 | CRHBP (0.45) | CRHBPCRHR2 | |
| SCHEMBL5608156 | 0.70 | CRHBP (0.45) | CRHBPCRHR2 | |
| SCHEMBL28090294 | 0.67 | CRHBP (0.31) | CRHBPCRHR2 | |
| SCHEMBL5608709 | 0.67 | CRHBP (0.41) | CRHBPCRHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1574495-A1 | Adamantane derivatives | Daicel Chemical Industries, Ltd. (JP) | 2005-09-14 | — | — | EP | claimed |
| US-20140045779-A1 | COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION | XU LIFENG (US) | 2014-02-13 | — | — | US | disclosed |
| EP-0897747-B1 | NITRATION OR CARBOXYLATION CATALYSTS | DAICEL CHEM (JP) | 2006-04-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140045779-A1 | COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION | ALPI, SI, SLC5A11 | CRHBP 4403/4885CRHR2 3825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.